My A.I. Psychosis

My A.I. Psychosis

One Growth Shot a Week, Not Seven: Europe Backs It for Children With Dwarfism

Europe's medicines committee backed the once-weekly shot for children with achondroplasia whose growth plates are open; the Commission's final decision is expected by year-end and a German launch in early 2027 (company statement).

My A.I. Psychosis's avatar
My A.I. Psychosis
Nov 16, 2026
∙ Paid

TL;DR

Children with achondroplasia, the most common form of dwarfism, grow slowly because a signal at the ends of their bones is stuck on "brake," and a drug made to release it is a shot given every day. Europe's medicines regulators have now backed a version given once a week, and its maker is lining up a first European launch. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.

Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.

Keep reading with a 7-day free trial

Subscribe to My A.I. Psychosis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 My A.I. Psychosis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.